Mitometh
Mitometh is a methylated derivative of Mitotane, developed as a potential therapeutic agent for adrenal cancer due to its adrenal-suppressing activity. It has been investigated in both in vitro and in vivo preclinical studies for targeting adrenocortical carcinoma.
Product Specifications
CAS Number
107465-03-2
Smiles
ClC1=CC=C (C=C1) C (C=2C=CC=CC2Cl) C (Cl) (Cl) C
Molecular Formula
C15H12Cl4
Molecular Weight
334.07
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4424404 1.0 µg DNA
Fam3b sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details orb2538330 100 µL
5HT2B Receptor Rabbit Polyclonal Antibody (BF750)
Sign In for Pricing
View Details 
VAng-Yyj3489-1mgEcoli 1 mg (E. coli)
Recombinant Mycobacterium Bovis panD Protein (aa 1-24)
Sign In for Pricing
View Details orb1606166 100 µL
Phospho-Bcl-2 (Ser70) Rabbit Polyclonal Antibody (BF594)
Sign In for Pricing
View Details